Cargando…

Exome sequencing in primary melanoma identifies novel drivers of melanoma progression

Detalles Bibliográficos
Autores principales:	Montagnani, Valentina, Benelli, Matteo, Apollo, Alessandro, Pandolfi, Silvia, Gerlini, Gianni, Borgognoni, Lorenzo, Stecca, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315282/ http://dx.doi.org/10.1186/1479-5876-13-S1-P2

Ejemplares similares

Thin and thick primary cutaneous melanomas reveal distinct patterns of somatic copy number alterations
por: Montagnani, Valentina, et al.
Publicado: (2016)

Regulation of melanoma initiating cells by Hedgehog signaling and SOX2
por: Santini, Roberta, et al.
Publicado: (2014)

Enhancing anti-melanoma immunity by electrochemotherapy and in vivo dendritic-cell activation
por: Gerlini, Gianni, et al.
Publicado: (2012)

Tolerogenic IDO1(+)CD83(−) Langerhans Cells in Sentinel Lymph Nodes of Patients with Melanoma
por: Gerlini, Gianni, et al.
Publicado: (2022)

ERK5 is activated by oncogenic BRAF and promotes melanoma growth
por: Tusa, Ignazia, et al.
Publicado: (2018)

SOX2 regulates self-renewal and tumorigenicity of human melanoma-initiating cells
por: Santini, R, et al.
Publicado: (2014)

Norepinephrine promotes tumor microenvironment reactivity through β3-adrenoreceptors during melanoma progression
por: Calvani, Maura, et al.
Publicado: (2014)

HEDGEHOG/GLI-E2F1 axis modulates iASPP expression and function and regulates melanoma cell growth
por: Pandolfi, S, et al.
Publicado: (2015)

The Role of Glycosylation in Melanoma Progression
por: De Vellis, Chiara, et al.
Publicado: (2021)

Individual cultures of melanoma tumor infiltrating lymphocytes possess distinct patterns of reactivity with mutated antigens identified by whole exome sequencing of autologous tumors
por: Crystal, Jessica S, et al.
Publicado: (2014)

UV exposure and melanoma prognostic factors : results from Clinical National Melanoma Registry (CNMR)
por: Montella, Maurizio, et al.
Publicado: (2014)

Clinical value of Melanoma Inhibitory Activity in stratifying malignant melanoma patients
por: Sandru, Angela, et al.
Publicado: (2015)

The Hedgehog-GLI Pathway Regulates MEK5-ERK5 Expression and Activation in Melanoma Cells
por: Tusa, Ignazia, et al.
Publicado: (2021)

Gender differences and outcome of melanoma patients
por: Morgese, Francesca, et al.
Publicado: (2015)

Identifying metabolomic features that predict metastasis of melanoma from a primary site
por: Shi, Xiaolei, et al.
Publicado: (2014)

Melanoma Inhibitory Activity and regional lymph node status in malignant melanoma patients
por: Sandru, Angela, et al.
Publicado: (2015)

Neuropilin-1 expressing melanoma cells as a model to study the aggressiveness of metastatic melanoma
por: Ruffini, Federica, et al.
Publicado: (2015)

KLF4 is regulated by RAS/RAF/MEK/ERK signaling through E2F1 and promotes melanoma cell growth
por: Riverso, M, et al.
Publicado: (2017)

Practicality of identifying mitochondria variants from exome and RNAseq data
por: Zhang, Pan, et al.
Publicado: (2015)

Malignant melanoma: an audit on delay in diagnosis
por: Lee, CWC, et al.
Publicado: (2015)

Complications of sequential immunotherapy in metastatic melanoma
por: Bufalino, Shams, et al.
Publicado: (2015)

NGS technology applied to melanoma cell lines
por: De Giorgi, Valeria, et al.
Publicado: (2013)

Immunologic hierarchy and promiscuity of melanoma helper peptides
por: Hu, Yinin, et al.
Publicado: (2013)

Molecular and immune heterogeneity in synchronous melanoma metastases
por: Reuben, Alexandre, et al.
Publicado: (2015)

Combined targeting of HEDGEHOG signaling and BRD4 as a novel therapeutic option against melanoma
por: Pietrobono, Silvia, et al.
Publicado: (2023)

Barasertib: a novel approach for the treatment of metastatic melanoma
por: Azzariti, Amalia, et al.
Publicado: (2014)

Predictors of toxicity for metastatic melanoma patients treated with ipilimumab
por: Valpione, Sara, et al.
Publicado: (2015)

GIFT4-augmented B cells for melanoma immunotherapy
por: Deng, Jiusheng, et al.
Publicado: (2014)

Immunoscore: a new possible approach for melanoma classification
por: Capone, Mariaelena, et al.
Publicado: (2014)

Atopic dermatitis and melanoma: A case-control study
por: Marasigan, Vivien, et al.
Publicado: (2015)

Antigen-specific TIL therapy for melanoma: a flexible platform for personalized cancer immunotherapy
por: Kelderman, Sander, et al.
Publicado: (2013)

Pilot clinical trials testing the safety and effects on the metastatic melanoma microenvironment of intratumoral interferon-gamma or imiquimod, plus a multipeptide melanoma vaccine
por: Mauldin, Ileana S, et al.
Publicado: (2015)

Hypoxia-dependent drivers of melanoma progression
por: D’Aguanno, Simona, et al.
Publicado: (2021)

Role of Protein Kinases in Hedgehog Pathway Control and Implications for Cancer Therapy
por: Montagnani, Valentina, et al.
Publicado: (2019)

Bim and PD-1 identify effector CD8 T cells responsive to anti-PD-1 therapy in metastatic melanoma patients
por: Dronca, Roxana, et al.
Publicado: (2015)

Intra-patient intra-tumoral immune heterogeneity is evident at progression on targeted therapy and immunotherapy for melanoma
por: Reuben, Alexandre, et al.
Publicado: (2014)

Surgical management of melanoma: an EORTC Melanoma Group survey
por: Testori, A, et al.
Publicado: (2013)

Melanoma skin cancer: could chromone derivatives be efficient chemopreventors?
por: Dias, Mafalda M, et al.
Publicado: (2010)

Apoptotic gene expression in melanoma cells treated with kaurenic acid
por: Rivero, María B, et al.
Publicado: (2012)

Antibody response to melanoma helper-peptide vaccine correlates with survival
por: Olson, Walter C, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_46mk5telqvomca6e156j8h39uh